Baseline Subfoveal Choroidal Thickness as a Predictor for Response to Short-Term Intravitreal Bevacizumab Injections in Diabetic Macular Edema

PURPOSE: This article aims to evaluate how the subfoveal choroidal thickness (SFCT) and best-corrected visual acuity (BCVA) respond to the intravitreal injection of bevacizumab and to assess the correlation between these changes. It will also assess the use of the baseline SFCT as a predictor for BC...

Descripción completa

Detalles Bibliográficos
Autores principales: Dweikat, Alaa, Jarrar, Arkan, Akkawi, Mohammad, Shehadeh, Mohammad, Aghbar, Ammar, Qaddumi, Jamal, Akkawi, Maha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536875/
https://www.ncbi.nlm.nih.gov/pubmed/34703204
http://dx.doi.org/10.2147/OPTH.S325951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536875/
https://www.ncbi.nlm.nih.gov/pubmed/34703204
http://dx.doi.org/10.2147/OPTH.S325951

Ejemplares similares